Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trialArnaud D Roth, Sabine Tejpar, Mauro Delorenzi, et al.
European Journal of Cancer (Oxford, England : 1990)|September 4, 2007
Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment GroupBernard Nordlinger, Eric Van Cutsem, Philippe Rougier, et al.
International Journal of Cancer|April 27, 2011
Evaluation of predictive models in daily practice for the identification of patients with Lynch syndromeChristophe Tresallet, Antoine Brouquet, Catherine Julié, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2008
Urgent need for a new staging system in advanced colorectal cancerGraeme J Poston, Joan Figueras, Felice Giuliante, et al.
Journal of the National Cancer Institute|April 5, 2017
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II TrialTheo Ruers, Frits Van Coevorden, Cornelis J A Punt, et al.
BMC Cancer|April 5, 2007
Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocksHeiko Fensterer, Bernhard Radlwimmer, Jörn Sträter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancerGraeme J Poston, René Adam, Steven Alberts, et al.
The American Journal of Gastroenterology|September 2, 2008
Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screeningCatherine Julié, Christophe Trésallet, Antoine Brouquet, et al.
The Lancet. Oncology|October 15, 2013
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trialBernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3Eric Van Cutsem, Roberto Labianca, György Bodoky, et al.
Pageof 7